Promising treatment for metastatic melanoma 'fast tracked' by FDA


Researchers from the John Theurer Cancer Center at Hackensack University Medical Center played an important role in a study that led to the Food & Drug Administration's recent fast tracking of ipilimumab, a promising treatment for metastatic melanoma.


[ Terug naar het hoofdmenu ]